Stay updated on Nivolumab in Metastatic Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Metastatic Bladder Cancer Clinical Trial page.

Latest updates to the Nivolumab in Metastatic Bladder Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedUpdated the Italy location entry from Napoli, Italy, 80131 to Naples, Italy, 80131 and updated the revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.3%

- Check71 days agoChange DetectedAdded a site-wide funding status notice and updated the page revision to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.3%

- Check78 days agoChange DetectedAdded a 'Show glossary' option and updated labels for QC criteria mentions and FEAR Act notices, including capitalization changes and a revision tag update from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page shows Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in Metastatic Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Metastatic Bladder Cancer Clinical Trial page.